New therapy helps immune system eradicate brain tumors

bySwedish Research CouncilGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.010Researchers from Uppsala University have developed a method that helps immune

Updated on: January 13,2024

New therapy helps immune system eradicate brain tumors

bySwedish Research CouncilGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.010Researchers from Uppsala University have developed a method that helps immune

Updated on:January 13,2024

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on: January 02,2024

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on:January 02,2024

'Most horrible' brain tumor patients falling through healthcare cracks, study shows

by University of EssexCredit: Unsplash/CC0 Public DomainPatients suffering from the "most horrible" rare brain tumor are falling through the cracks of mental health provision, Universit

Updated on: February 18,2024

'Most horrible' brain tumor patients falling through healthcare cracks, study shows

by University of EssexCredit: Unsplash/CC0 Public DomainPatients suffering from the "most horrible" rare brain tumor are falling through the cracks of mental health provision, Universit

Updated on:February 18,2024

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy

Updated on: March 09,2024

Designing an emergency stop switch for immunotherapies

by Ecole Polytechnique Federale de LausanneA mollecule allows for 'switching off' the therapy when a cancer patient's life is in danger. Credit: EPFLImmunotherapy, unlike chemotherapy

Updated on:March 09,2024

Research reveals previously unknown qualities of a gene vital to a cell's mitochondrial structure and function

by Rachel Sauer,University of Colorado at BoulderModel of the human S-OPA1 bound to membranes. Credit:Nature(2023). DOI: 10.1038/s41586-023-06441-6A key takeaway from first-year biol

Updated on: July 02,2024

Research reveals previously unknown qualities of a gene vital to a cell's mitochondrial structure and function

by Rachel Sauer,University of Colorado at BoulderModel of the human S-OPA1 bound to membranes. Credit:Nature(2023). DOI: 10.1038/s41586-023-06441-6A key takeaway from first-year biol

Updated on:July 02,2024

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on: January 12,2024

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

Updated on:January 12,2024

Hormone therapy for breast cancer linked with lower dementia risk

byUniversity of PittsburghCredit: CC0 Public DomainHormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's dise

Updated on: July 17,2024

Hormone therapy for breast cancer linked with lower dementia risk

byUniversity of PittsburghCredit: CC0 Public DomainHormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's dise

Updated on:July 17,2024

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft

Updated on: May 27,2024

Colorectal cancer cells killed by assassin antibody, team finds

by University of SaskatchewanCredit: University of SaskatchewanColorectal cancer is the second leading cause of death from cancer in North America and is often diagnosed at an advanced stage, aft

Updated on:May 27,2024

New research explores policies on timely breast cancer diagnosis for underserved women

by University of Illinois at ChicagoCredit: CC0 Public DomainA new study from University of Illinois at Chicago researchers suggests delays in diagnosis and use of under-resourced health centers

Updated on: March 08,2024

New research explores policies on timely breast cancer diagnosis for underserved women

by University of Illinois at ChicagoCredit: CC0 Public DomainA new study from University of Illinois at Chicago researchers suggests delays in diagnosis and use of under-resourced health centers

Updated on:March 08,2024

Drug combination prompts immune response in some resistant pancreatic cancers

byJohns Hopkins University School of MedicineRadiologic scans and change in CA19.9 of the three responders during the course of entinostat plus nivolumab therapy. Credit:Nature Communicati

Updated on: December 01,2024

Drug combination prompts immune response in some resistant pancreatic cancers

byJohns Hopkins University School of MedicineRadiologic scans and change in CA19.9 of the three responders during the course of entinostat plus nivolumab therapy. Credit:Nature Communicati

Updated on:December 01,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024

Renowned tumor suppressor has prominent role in tissue repair, study finds

by Krista Conger,Stanford UniversityCredit: AI-generated imageA protein famed among scientists and clinicians for its ability to suppress the development of many types of tumors may just be moon

Updated on: January 23,2024

Renowned tumor suppressor has prominent role in tissue repair, study finds

by Krista Conger,Stanford UniversityCredit: AI-generated imageA protein famed among scientists and clinicians for its ability to suppress the development of many types of tumors may just be moon

Updated on:January 23,2024